BofA lowered the firm’s price target on Iqvia (IQV) to $190 from $235 and keeps a Buy rating on the shares. Sentiment for Life Sciences and ...

Barclays downgraded Iqvia (IQV) to Equal Weight from Overweight with a price target of $170, down from $235. The firm moved to the sidelines on ...

LinkedIn is providing its owner with a billion willing guinea pigs, perhaps giving it an edge in the ai race. With its ...

IQVIA Holdings Inc. closed 42.44% below its 52-week high of $252.88, which the company reached on August 29th.

Shares of IQVIA Holdings Inc. IQV slipped 8.79% to $143.22 Thursday, on what proved to be an all-around poor trading session ...

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BRIDGEWATER, N.J. and BENGALURU, India, April 10, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the ...